OpenAlex
PricingAboutJobs
Log inGet started
Work

Once-daily dosing of levocabastine has comparable efficacy to twice-daily dosing in the treatment of allergic rhinitis assessed in an allergen challenge chamber

HTML

Year: 2015
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: International Journal of Clinical Pharmacology and Therapeutics
DOI: 10.5414/cp202389
Authors: Robert D. Murdoch, Philippe Bareille, Diane Ignar, Stephen Mark, Sam R. Miller, Ashutosh Gupta, Anne-Marie Salapatek, Piyush Patel
Language: English

Topic: Allergic Rhinitis and Sensitization
Subfield: Immunology and Allergy
Field: Medicine
Domain: Health Sciences
Keywords: levocabastine, allergic rhinitis, once-daily dosing, twice-daily dosing, dosing regimen comparison, nasal spray, allergen challenge, nasal symptom score, non-inferiority, steady-state pharmacokinetics, antihistamines
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2473809525
FWCI: 0.89
Cites:
Cited by: 6
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security